Literature DB >> 23645689

High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols.

Kajsa Paulsson1, Erik Forestier, Mette K Andersen, Kirsi Autio, Gisela Barbany, Georg Borgström, Lucia Cavelier, Irina Golovleva, Sverre Heim, Kristiina Heinonen, Randi Hovland, Johann H Johannsson, Eigil Kjeldsen, Ann Nordgren, Lars Palmqvist, Bertil Johansson.   

Abstract

Between 1992 and 2008, 713 high hyperdiploid acute lymphoblastic leukemias in children aged 1-15 years were diagnosed and treated according to the Nordic Society for Pediatric Hematology and Oncology acute lymphoblastic leukemia 1992/2000 protocols. Twenty (2.8%) harbored t(1;19), t(9;22), der(11q23), or t(12;21). The median age of patients with "classic" high hyperdiploidy was lower than that of patients with translocation-positive high hyperdiploidy (P<0.001). Cases with triple trisomies (+4, +10, +17), comprising 50%, had higher modal numbers than the triple trisomy-negative cases (P<0.0001). The probabilities of event-free survival and overall survival were lower for those with white blood cell counts ≥ 50 × 10(9)/L (P=0.017/P=0.009), ≥ 5% bone marrow blasts at day 29 (P=0.001/0.002), and for high-risk patients (P<0.001/P=0.003), whereas event-free, but not overall, survival, was higher for cases with gains of chromosomes 4 (P<0.0001), 6 (P<0.003), 17 (P=0.010), 18 (P=0.049), and 22 (P=0.040), triple trisomies (P=0.002), and modal numbers >53/55 (P=0.020/0.024). In multivariate analyses, modal number and triple trisomies were significantly associated with superior event-free survival in separate analyses with age and white blood cell counts. When including both modal numbers and triple trisomies, only low white blood cell counts were significantly associated with superior event-free survival (P=0.009). We conclude that high modal chromosome numbers and triple trisomies are highly correlated prognostic factors and that these two parameters identify the same subgroup of patients characterized by a particularly favorable outcome.

Entities:  

Mesh:

Year:  2013        PMID: 23645689      PMCID: PMC3762100          DOI: 10.3324/haematol.2013.085852

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  37 in total

1.  Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study.

Authors:  M B Harris; J J Shuster; A Carroll; A T Look; M J Borowitz; W M Crist; R Nitschke; J Pullen; C P Steuber; V J Land
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

Review 2.  Fifty years of studies of the biology and therapy of childhood leukemia.

Authors:  J H Kersey
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

3.  Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia.

Authors:  C H Pui; S C Raimondi; R K Dodge; G K Rivera; L A Fuchs; M Abromowitch; A T Look; W L Furman; W M Crist; D L Williams
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

4.  Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia.

Authors:  H Rieder; W D Ludwig; W Gassmann; J Maurer; J W Janssen; N Gökbuget; S Schwartz; E Thiel; H Löffler; C R Bartram; D Hoelzer; C Fonatsch
Journal:  Br J Haematol       Date:  1996-12       Impact factor: 6.998

5.  Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia.

Authors:  N Onodera; N R McCabe; C M Rubin
Journal:  Blood       Date:  1992-07-01       Impact factor: 22.113

6.  Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia.

Authors:  C H Pui; S C Raimondi; M J Borowitz; V J Land; F G Behm; D J Pullen; M L Hancock; J J Shuster; C P Steuber; W M Crist
Journal:  J Clin Oncol       Date:  1993-07       Impact factor: 44.544

7.  Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Groupe Français de Cytogénétique Hématologique.

Authors: 
Journal:  Leukemia       Date:  1993-01       Impact factor: 11.528

8.  Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.

Authors:  Meir Wetzler; Richard K Dodge; Krzysztof Mrózek; Carleton C Stewart; Andrew J Carroll; Ramana Tantravahi; James W Vardiman; Richard A Larson; Clara D Bloomfield
Journal:  Br J Haematol       Date:  2004-02       Impact factor: 6.998

9.  Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia.

Authors:  S C Raimondi; C H Pui; M L Hancock; F G Behm; L Filatov; G K Rivera
Journal:  Leukemia       Date:  1996-02       Impact factor: 11.528

10.  Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.

Authors:  N A Heerema; J Harbott; S Galimberti; B M Camitta; P S Gaynon; G Janka-Schaub; W Kamps; G Basso; C-H Pui; M Schrappe; M-F Auclerc; A J Carroll; V Conter; C J Harrison; J Pullen; S C Raimondi; S Richards; H Riehm; H N Sather; J J Shuster; L B Silverman; M G Valsecchi; M Aricò
Journal:  Leukemia       Date:  2004-04       Impact factor: 11.528

View more
  12 in total

Review 1.  Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.

Authors:  Christopher Wenzinger; Eli Williams; Alejandro A Gru
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

2.  Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.

Authors:  Brent Wood; David Wu; Beryl Crossley; Yunfeng Dai; David Williamson; Charles Gawad; Michael J Borowitz; Meenakshi Devidas; Kelly W Maloney; Eric Larsen; Naomi Winick; Elizabeth Raetz; William L Carroll; Stephen P Hunger; Mignon L Loh; Harlan Robins; Ilan Kirsch
Journal:  Blood       Date:  2017-12-28       Impact factor: 22.113

Review 3.  Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children.

Authors:  Oskar A Haas; Arndt Borkhardt
Journal:  Leukemia       Date:  2022-10-20       Impact factor: 12.883

4.  Evolutionary trajectories of hyperdiploid ALL in monozygotic twins.

Authors:  C M Bateman; D Alpar; A M Ford; S M Colman; D Wren; M Morgan; L Kearney; M Greaves
Journal:  Leukemia       Date:  2014-06-04       Impact factor: 11.528

Review 5.  New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.

Authors:  Anthony V Moorman
Journal:  Haematologica       Date:  2016-04       Impact factor: 9.941

6.  High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome.

Authors:  L Chilton; G Buck; C J Harrison; R P Ketterling; J M Rowe; M S Tallman; A H Goldstone; A K Fielding; A V Moorman
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

7.  Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL.

Authors:  Oscar Molina; Meritxell Vinyoles; Isabel Granada; Heleia Roca-Ho; Francisco Gutierrez-Agüera; Luis Valledor; Carlos M López-López; Pablo Rodríguez-González; Juan L Trincado; Sofía T Menéndez; Deepali Pal; Paola Ballerini; Monique L den Boer; Isabel Plensa; M Mar Perez-Iribarne; Sandra Rodríguez-Perales; María José Calasanz; Manuel Ramírez-Orellana; René Rodríguez; Mireia Camós; Maria Calvo; Clara Bueno; Pablo Menéndez
Journal:  Blood       Date:  2020-07-16       Impact factor: 22.113

8.  An unusual case of high hyperdiploid childhood ALL with cryptic BCR/ABL1 rearrangement.

Authors:  Libuse Lizcova; Zuzana Zemanova; Halka Lhotska; Jan Zuna; Lenka Hovorkova; Ester Mejstrikova; Eva Malinova; Jana Rabasova; Ivan Raska; Lucie Sramkova; Jan Stary; Kyra Michalova
Journal:  Mol Cytogenet       Date:  2014-10-24       Impact factor: 2.009

9.  Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.

Authors:  Hui Zhang; Anthony Pak-Yin Liu; Meenakshi Devidas; Shawn Hr Lee; Xueyuan Cao; Deqing Pei; Michael Borowitz; Brent Wood; Julie M Gastier-Foster; Yunfeng Dai; Elizabeth Raetz; Eric Larsen; Naomi Winick; W Paul Bowman; Seth Karol; Wenjian Yang; Paul L Martin; William L Carroll; Ching-Hon Pui; Charles G Mullighan; William E Evans; Cheng Cheng; Stephen P Hunger; Mary V Relling; Mignon L Loh; Jun J Yang
Journal:  J Natl Cancer Inst       Date:  2021-04-06       Impact factor: 11.816

10.  Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries.

Authors:  Catarina Lundin; Erik Forestier; Mette Klarskov Andersen; Kirsi Autio; Gisela Barbany; Lucia Cavelier; Irina Golovleva; Sverre Heim; Kristiina Heinonen; Randi Hovland; Johann H Johannsson; Eigil Kjeldsen; Ann Nordgren; Lars Palmqvist; Bertil Johansson
Journal:  J Hematol Oncol       Date:  2014-04-11       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.